Rituximab for Graves’ Orbitopathy
Lauren LaBryer, MD, Endocrinology Fellow
Upon completion of this activity, participants will be able to: Recognize the current limitations of conventional treatment for thyroid eye disease. To review the literature available regarding rituximab therapy in management of Graves’ orbitopathy.
For more information contact:
Department of Medicine/Endocrinology and Diabetes